Fundraising Fox

Maxwell Biomedical

2 known investors

Maxwell Biomedical develops a device-based alternative to catheter ablation for atrial fibrillation, using closed-loop adaptive left atrial multisite pacing and Spatial Resynchronization Therapy (SRT) to terminate AF without high-energy shock. Its work centers on wirelessly powered leadless pacemakers and cardiac resynchronization technology for cardiac rhythm disorders.

Founders & leadership

RW
Randy WernethCEO, President
TC
Timothy CorviSr. VP, R&D
DC
Derrick ChouVP, Science & Technology
BC
Ben CoppolaDirector of SRT
WB
Walter BomelaDynamical Systems Scientist
JC
J. Chris FlahertyIP Strategist
Ragnar ÓlafssonSr. Pr. Systems Engineer

Investors · 2

Competitors · 4

by search overlap

Companies competing with Maxwell Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Maxwell Biomedical do?
Maxwell Biomedical develops a device-based alternative to catheter ablation for atrial fibrillation, using closed-loop adaptive left atrial multisite pacing and Spatial Resynchronization Therapy (SRT) to terminate AF without high-energy shock. Its work centers on wirelessly powered leadless pacemakers and cardiac resynchronization technology for cardiac rhythm disorders.
Who are Maxwell Biomedical's investors?
Maxwell Biomedical's investors include Broadview Ventures, RiverVest Venture Partners.